arsenic has been researched along with Lymphoma, T Cell, Peripheral in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Fukuhara, N; Izutsu, K; Kang, HJ; Kim, WS; Ko, PS; Kwong, YL; Nagahama, F; Nagai, H; Nakajima, H; Negoro, E; Sonehara, Y; Suehiro, Y; Terui, Y; Tien, HF; Tobinai, K; Uchida, T; Yamamoto, K; Yoon, DH | 1 |
| Nagahama, F; Sonehara, Y; Yao, K | 1 |
| Ishizawa, K; Kim, WS; Nagahama, F; Nagai, H; Ogura, M; Sonehara, Y; Suehiro, Y; Tobinai, K; Uchida, T; Uike, N | 1 |
| Bae, H; Ito, I; Kubota, K; Nagahama, F; Okamoto, T; Sonehara, Y; Tateishi, U; Tsuchiya, J | 1 |
4 trial(s) available for arsenic and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study.
Topics: Arsenicals; Glutathione; Humans; Lymphoma, T-Cell, Peripheral; Neutropenia | 2023 |
[Pharmacological profile and clinical study results of darinaparsin (DARVIAS
Topics: Arsenic; Arsenicals; Cystine; Glutathione; Humans; Lymphoma, T-Cell, Peripheral | 2023 |
Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea.
Topics: Adult; Aged; Aged, 80 and over; Arsenicals; Female; Glutathione; Humans; Japan; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Republic of Korea; Time Factors; Treatment Outcome; Young Adult | 2021 |
Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multice
Topics: Aged; Arsenicals; Asia; Biomarkers; Female; Fluorodeoxyglucose F18; Glutathione; Humans; Internationality; Japan; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; North America; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Radiology; Radiopharmaceuticals; Reference Standards; Societies, Medical; Treatment Outcome | 2018 |